Roy F. Chemaly

Roy F. Chemaly is a Professor of Medicine and a high-ranking senior faculty member at The University of Texas MD Anderson Cancer Center. His research focuses on transplant infectious diseases, specifically the epidemiology, virology, and immunology of infections in immunocompromised hosts, including hematologic malignancy and hematopoietic cell transplant patients. His recent work addresses the evolving epidemiology of invasive mold infections, resistance mechanisms in ceftazidime-avibactam-resistant Escherichia coli, and the management of cytomegalovirus and herpesvirus infections following cellular therapies. He has authored international consensus guidelines for the European Conference on Infections in Leukaemia and the American Society for Transplantation and Cellular Therapy, and has published extensively on novel antiviral agents such as maribavir.